A study investigated the neural mechanisms behind aggressive behaviors in patients with Alzheimer disease and amnestic mild cognitive impairment, revealing distinct associations between brain activity and...
A study on mild cognitive impairment found that depression and agitation are linked to regional brain atrophy and faster cognitive decline, suggesting these symptoms may indicate a higher risk for...
A cluster-randomized controlled trial examined the impact of personalized music on reducing agitation in nursing home residents with dementia, revealing significant reductions in verbally agitated behaviors...
In a recent interview with Consultant360, Kasia Rothenberg, MD, PhD, a geriatric psychiatrist at the Cleveland Clinic Lou Ruvo Center for Brain Health, described the many obstacles to accurate testing. Do...
In their presentation at the Practical Updates in Primary Care 2023 Virtual Series, Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C reviewed the pathophysiological mechanisms of agitation...
A new study found transcranial pulse stimulation treatment may improve behavioral symptoms such as aggression or agitation in patients with Alzheimer disease. Take our quiz to test your knowledge on its...
A new study found transcranial pulse stimulation treatment may improve behavioral symptoms such as aggression or agitation in patients with Alzheimer disease. Take our quiz to test your knowledge on its...
In this video, Kasia Rothenberg, MD, PhD, describes Alzheimer disease-related agitation, details the difficulty in testing for Alzheimer disease-related agitation, looks ahead to potential treatment options...
In this podcast, Leslie Citrome, MD, MPH, talks about resources and strategies of care that caregivers of people with agitation in Alzheimer disease can implement. He talks about how caregivers can be...
Jeff Cummings, MD, ScD; Carolyn Clevenger, DNP, RN, GNP-BC, FAANP, FGSA, FAAN; Tatyana Gurvich, PharmD, BCGP; Lakelyn Hogan Eichenberger, PhD, MA, MBA; W. Clay Jackson, MD, DipTh; Sean Tunis, MD, MSc; Kate Zhong, MD, MSc, FRCP
Agitation in Alzheimer’s dementia is a serious neuropsychiatric condition that is highly prevalent and underdiagnosed. It contributes to adverse clinical outcomes for people living with Alzheimer’s dementia...
In this video, Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C provide the take-home messages from their session “Agitation in Alzheimer’s Dementia: Progress for an Age-Old Problem” at our...
In a small clinical trial, researchers found that patients taking suvorexant, an FDA-approved treatment for insomnia, had reduced levels of amyloid beta (amyloid-β) and tau phosphorylation proteins, which...
